Your browser is out of date
With an updated browser, you will have a better Medtronic website experience. Update my browser now.
Inceptiv™ is the most advanced SCS system with closed-loop technology1-3 for chronic pain relief.
Download brochure
Inceptiv™ Spinal Cord Stimulator
Discover why Inceptiv™ is the most advanced SCS system with closed-loop technology
Fixed-output systems do not account for shifts in lead-to-spinal cord distance, which may result in inconsistent therapy dose4 and can compromise patient experience.
With fixed-output systems, patients need to make adjustments to deliver optimal therapy, regardless of waveform. Under- and overdosing can lead to variable therapy experience.
Variability in electrode distance to spinal cord due to activities and position
Inceptiv™ SCS system with closed loop technology senses* neutral response and automatically adjusts stimulation to maintain therapy level during all patients activities.
Automatic:
does not depend on adjustments from the patient to maintain stimulation
Responsive:
instantly adjusts therapy delivery in real time
Seamless:
provides consistent therapy while patients perform a full range of daily activities
Closed-loop SCS offers flexibility of therapy programming, based on patient preference.
highest back pain responder rate reported at 12 months in similar RCTs‡ (≥50% improvement).1
of DTM™ SCS patients were profound back pain responders (≥80% pain relief).3
82%
of patients are expected to need an
MRI within 5 years post implant6
90%
access to MRI scanners7§
✔ Able to scan high impedance or fractured lead
✔ Able to scan fully discharged device
✔ 1.5T and 3T MR conditional whole body normal operating mode
✔ Able to scan patient in prone position, e.g., breast MRI
Click to learn more about DTM™ SCS, a proprietary waveform supported by pre-clinical research and clinical research delivering Superior Pain Relief. Proven.1
Learn moreand access detailed product information, including spec sheets, videos, and presentations.
Visit Medtronic Academy § 8 Under specific conditions. Refer to product labeling for full list of conditions.
Sensing signals may not be measurable in all cases.
DTM™ SCS superior outcomes demonstrated using open-loop SCS therapy.
Descriptive comparison, including studies with similar design (RCT; randomization >100 subjects; comparing 2 SCS therapies; with at least 12-months follow-up) and patient populations (inclusion/exclusion criteria; baseline demographics) with back pain responder rates reported. This is not based on a statistical analysis of outcomes between studies.
Fishman M, Cordner H, Justiz R, et al. 12-Month Results from Multicenter, Open-Label, Randomized Controlled Clinical Trial Comparing Differential Target Multiplexed Spinal Cord Stimulation and Traditional Spinal Cord Stimulation in Subjects with Chronic Intractable Back Pain and Leg Pain. Pain Pract. 2021; 21: 912– 923. doi:10.1111/papr.13066
Inceptiv IFU with MRI labeling. 2023. M010773C001 Rev B. M009826C001 Rev B. M939858A028 Rev A.
Evoke SCS System User Manual. 2022 Saluda Medical. CLINUMAN-002426 Revision: 16.00.
ECHO MAC Final Clinical Study Report V1.0 2021-08-18
Vallejo R, Chakravarthy K, Will A, Trutnau K, Dinsmoor D. A new direction for closed-loop spinal cord stimulation: combining contemporary therapy paradigms with evoked compound action potential sensing. J Pain Res. 2021;14:3909-3918. doi 10.2147/JPR. S344568.
Desai MJ, Hargens LM, Breitenfeldt MD, et al. The rate of magnetic resonance imaging in patients with spinal cord stimulation. Spine. 2015;40(9):E531-537
Diagnostic Imaging Equipment Servicing. Market Insights. Western Europe: Clarivate; 2022. Report No. 47031053